Publication | Closed Access
The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy
81
Citations
10
References
1993
Year
MedicineCancer ManagementCombined Modality TreatmentCancer TreatmentRadiation OncologyOncologyCancer ChemotherapyHealth Care CostsCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1